4/A//SEC Filing
ENDRA Life Sciences Inc. 4/A
Accession 0001209191-17-042112
$NDRACIK 0001681682operating
Filed
Jun 27, 8:00 PM ET
Accepted
Jun 28, 4:14 PM ET
Size
5.8 KB
Accession
0001209191-17-042112
Insider Transaction Report
Form 4/AAmended
Michelon Francois Roger
DirectorChief Executive Officer
Transactions
- Award
Stock Options
2017-06-09+31,960→ 31,960 totalExercise: $4.55Exp: 2025-05-12→ Common Stock (31,960 underlying)
Footnotes (2)
- [F1]These Stock Options become exercisable in three equal annual installments beginning on May 12, 2018.
- [F2]This amendment is being filed to correct the expiration date of these Stock Options, which was inadvertantly reported as May 12, 2022. The correct expiration date is May 12, 2025.
Documents
Issuer
ENDRA Life Sciences Inc.
CIK 0001681682
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001681682
Filing Metadata
- Form type
- 4/A
- Filed
- Jun 27, 8:00 PM ET
- Accepted
- Jun 28, 4:14 PM ET
- Size
- 5.8 KB